Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
06/03/2004 | WO2004046090A2 Aryl ureido derivatives and their medical use |
06/03/2004 | WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring |
06/03/2004 | WO2004045607A1 Novel hydroxyindoles, use as inhibitors of phosphodiesterase 4 and method for production thereof |
06/03/2004 | WO2004045597A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
06/03/2004 | WO2004033418A3 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
06/03/2004 | WO2004026236A3 Cyclopentyl indole derivatives |
06/03/2004 | WO2004002419A3 Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment |
06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
06/03/2004 | US20040106826 Process for synthesizing L--methylene glutamic acid and analogs |
06/03/2004 | US20040106792 Biphenyl compound |
06/03/2004 | US20040106669 inhibitor against type-X sPLA2 (secretary PLA2) as an active ingredient |
06/03/2004 | US20040106630 Bicyclic protein kinase inhibitors |
06/03/2004 | US20040106618 3-heteroarylidene-2-indolinone compounds useful in the prevention and treatment of protein kinase related cellular disorders such as cancer |
06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |
06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
06/03/2004 | US20040106597 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
06/03/2004 | US20040106560 such as N1-L-Arginylspermidine for protecting from damage from extended ischemic/hypoxic events |
06/03/2004 | DE10253426A1 Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
06/03/2004 | DE10252665A1 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate 4-aminomethyl-1-aryl-cyclohexylamine derivatives |
06/03/2004 | CA2506735A1 Indole derivatives as somatostatin agonists or antagonists |
06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
06/03/2004 | CA2506232A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
06/03/2004 | CA2506010A1 A method for deuteration of a heterocyclic ring |
06/03/2004 | CA2505988A1 Novel hydroxyindoles, use as inhibitors of phosphodiesterase 4 and method for production thereof |
06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
06/03/2004 | CA2502705A1 Aryl ureido derivatives and their medical use |
06/02/2004 | EP1424335A1 Indole derivatives |
06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
06/02/2004 | EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
06/02/2004 | EP1423365A1 Process for the preparation of indole derivatives |
06/02/2004 | EP1423363A1 Oral antidiabetic agents |
06/02/2004 | EP1423356A2 Novel aminobenzoephenones |
06/02/2004 | EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins |
06/02/2004 | EP1423006A1 Agonists and antagonists of 5h 3?-like receptors of invertebrate s as pesticides |
06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
06/02/2004 | CN1501928A Small molecule compositions for binding to hsp90 |
06/02/2004 | CN1501914A Indoline derivative and process for producing the same |
06/02/2004 | CN1500787A Cyclic nitrones and pharmaceutical compositions containing them |
06/02/2004 | CN1500779A Cyclic nitrones and pharmaceutical compositions containing them |
06/02/2004 | CN1500773A Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
06/02/2004 | CN1500769A Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
06/02/2004 | CN1152040C Carbazole derivatives, preparing process thereof and pharmaceutical combination containing the same |
06/01/2004 | US6743926 Process for the preparation of indole derivatives and intermediates of the process |
06/01/2004 | US6743817 Substituted fused pyrroleimines and pyrazoleimines |
06/01/2004 | US6743810 Indol-3-yl derivatives |
06/01/2004 | US6743796 Psychological disorders; schizophrenia; parkinson's disease |
06/01/2004 | US6743793 Dp receptor antagonist; prostaglandin d |
06/01/2004 | US6743373 Reagent based on enantiopure amino acid in which amino group carries activating group to form active precursor of isocyanate group and carboxyl group is substituted; separation of enantiomers having free functional group |
05/27/2004 | WO2004043958A1 Fused heterocyclic compounds |
05/27/2004 | WO2004043920A1 Polymorphs of bicifadine hydrochloride |
05/27/2004 | WO2004043919A1 A process for the preparation of 3-and 4-aminophthalimide. |
05/27/2004 | WO2004043909A1 Cyclohexylurea derivatives |
05/27/2004 | WO2004043900A2 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives |
05/27/2004 | WO2004043899A1 4-aminomethyl-1-aryl-cyclohexylamine derivatives |
05/27/2004 | WO2004043362A2 Acyl guanidine compounds and use thereof |
05/27/2004 | WO2004043350A2 PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR α4/PAXILLIN BINDING |
05/27/2004 | WO2004043336A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
05/27/2004 | WO2003016276A3 3-substituted oxindole beta-3 agonists |
05/27/2004 | US20040102646 Method of resolving optical isomers of amino acid derivative |
05/27/2004 | US20040102638 Polymorphs of bicifadine hydrochloride |
05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
05/27/2004 | US20040102509 Kinase inhibitors for the treatment of disease |
05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
05/27/2004 | US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
05/27/2004 | US20040102491 Antimicrobial agents |
05/27/2004 | US20040102467 Antiinflammatory agents; central nervous system disorders; antiproliferative agents |
05/27/2004 | US20040102458 Antiproliferative agents; antitumor agents; binding to chaperone protein |
05/27/2004 | US20040102442 Central nervous system disorders; brain disorders |
05/27/2004 | US20040102437 Prevention cytokine migration; hypotensive agents; asthma therapy |
05/27/2004 | US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders |
05/27/2004 | US20040100188 Anthracene derivative and organic electroluminescence device using the derivative |
05/27/2004 | DE10253322A1 New 4-(alkyl, alkenyl or alkynyl)-cyclohexylamine derivatives, are ORL1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, senile dementia, withdrawal symptoms or especially pain |
05/27/2004 | DE10252650A1 New 1,4-disubstituted cyclohexylamine derivatives, are opioid receptor like-receptor 1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, senile dementia, withdrawal symptoms or especially pain |
05/27/2004 | CA2505372A1 Fused heterocyclic compounds |
05/27/2004 | CA2505003A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
05/27/2004 | CA2504732A1 Polymorphs of bicifadine hydrochloride |
05/26/2004 | EP1422553A1 Improved base precursors for use in a photothermographic element |
05/26/2004 | EP1421634A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
05/26/2004 | EP1421064A1 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives |
05/26/2004 | EP1420781A2 Analgetic pyrroline derivatives |
05/26/2004 | EP1420644A1 Substituted propargylamines |
05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
05/26/2004 | CN1151161C Medicine nitrate salts |
05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
05/26/2004 | CN1151129C 2-acryl-3-substituted indoacetamide derivative and its medical application |
05/26/2004 | CN1151128C Process for preparing pineal hormone |
05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
05/25/2004 | US6740754 Process to produce oxazolidinones |
05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
05/25/2004 | US6740673 Quarternary ammonium compounds |
05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |